4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism-related enzymes gene polymorphisms, NNK metabolites levels and urothelial carcinoma

作者: Chi-Jung Chung , Yeong-Shiau Pu , Horng-Sheng Shiue , Hui-Ling Lee , Pinpin Lin

DOI: 10.1016/J.TOXLET.2012.11.002

关键词:

摘要: Gene polymorphisms of the 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism-related enzymes-cytochrome P450 (CYP) monooxygenase 2A13 (CYP2A13) and UDP-glucuronosyltransferases (UGT)-2B7 could contribute to levels NNK-related metabolites in urine, thereby increasing susceptibility urothelial carcinoma (UC). Therefore, our study aimed evaluate roles two gene (CYP2A13 UGT2B7) NNK enzymes carcinogenesis UC Taiwan. A hospital-based pilot case-control was conducted. There were 121 cases age- sex-matched healthy participants recruited from March 2007 April 2009. Urine samples analyzed for using liquid chromatography-tandem mass spectrometry method. Genotyping conducted a polymerase chain reaction-restriction fragment length polymorphism technique. ANCOVA multivariate logistic regression applied data analyses. In controls, former smokers had significantly higher total NNAL NNAL-Gluc than never or current smokers. Subjects carrying UGT2B7 268 His/Tyr Tyr/Tyr genotype lower those His/His genotype. However, no association seen between CYP2A13 risk after adjustment age sex. Significant dose -response associations NNAL, free ratios NNAL/total NNAL-Gluc/total observed. future, large-scale studies will be required verify single nucleotide risk.

参考文章(40)
Neil E. Caporaso, Martin M. Oken, Majda Haznadar, Mindy S. Geisser, Kristin E Anderson, Brian G Van Ness, Chap T Le, Timothy R Church, Salwan B. Abdullah, Stephen S Hecht, Interaction of CYP1B1, cigarette-smoke carcinogen metabolism, and lung cancer risk International journal of molecular epidemiology and genetics. ,vol. 1, pp. 295- 309 ,(2010)
Gangqiao Zhou, Dongxin Lin, Xiaoping Miao, Bingtao Hao, Fuchu He, Wen Tan, Haijian Wang, Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK. Cancer Research. ,vol. 63, pp. 8057- 8061 ,(2003)
Raunio H, Hoffman Sm, Mohrenweiser H, Huang Jd, Rautio A, Fernandez-Salguero P, Evans We, Cholerton S, Pelkonen O, A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles. American Journal of Human Genetics. ,vol. 57, pp. 651- 660 ,(1995)
R Sharma, M Ahuja, NK Panda, M Khullar, Polymorphisms in CYP2A13 and UGT1A7 genes and head and neck cancer susceptibility in North Indians. Oral Diseases. ,vol. 16, pp. 760- 768 ,(2010) , 10.1111/J.1601-0825.2010.01683.X
Jeannette Bigler, John D. Potter, Johanna W. Lampe, Angela C. Bush, Prevalence of Polymorphisms in the Human UDP-Glucuronosyltransferase 2B Family: UGT2B4(D458E), UGT2B7(H268Y), and UGT2B15(D85Y) Cancer Epidemiology, Biomarkers & Prevention. ,vol. 9, pp. 329- 333 ,(2000)
Dominique Kavvadias, Gerhard Scherer, Michael Urban, Francis Cheung, Graham Errington, Jim Shepperd, Mike McEwan, Simultaneous determination of four tobacco-specific N-nitrosamines (TSNA) in human urine. Journal of Chromatography B. ,vol. 877, pp. 1185- 1192 ,(2009) , 10.1016/J.JCHROMB.2009.03.009
C. Ramana Bhasker, Wendy McKinnon, Andrew Stone, Angus CT Lo, Takahiro Kubota, Takashi Ishizaki, John O. Miners, Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance. Pharmacogenetics. ,vol. 10, pp. 679- 685 ,(2000) , 10.1097/00008571-200011000-00002